EUVIMEDEUVIMED entdecken
Crossref

EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer

Elvis Boamah, Qudus Ibrahim, Lordcarse Kwinji, Ruchi Patel, Dolapo Ajayi, Michael Danquah

Synergy · 2015

DOI: 10.1016/j.synres.2015.05.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synergy, 2015. Verfasst von Elvis Boamah und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Center Teaching Research Excellence Seed Grant Award from Chicago State University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Center Teaching Research Excellence Seed Grant Award from Chicago State University

Zitieren

APA

Boamah, E., Ibrahim, Q., Kwinji, L., Patel, R., Ajayi, D., & Danquah, M. (2015). EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer. Synergy. https://doi.org/10.1016/j.synres.2015.05.001

Vancouver

Boamah E, Ibrahim Q, Kwinji L, Patel R, Ajayi D, Danquah M. EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer. Synergy. 2015. doi:10.1016/j.synres.2015.05.001

BibTeX
@article{Boamah2015,
  author = {Boamah, Elvis and Ibrahim, Qudus and Kwinji, Lordcarse and Patel, Ruchi and Ajayi, Dolapo and Danquah, Michael},
  title = {EGFR inhibitors in combination with cyclopamine as chemotherapeutic strategy for treating breast cancer},
  journal = {Synergy},
  year = {2015},
  doi = {10.1016/j.synres.2015.05.001}
}
Kostenlos starten →